Skip to content

Blood Biomarker Study to Diagnose Adolescent Sport Concussion

Brain Concussion

Concussions are one of the most complex conditions to manage in sport medicine due to the individualized clinical presentation, caused by a complex neurometabolic cascade, and the lack of a diagnostic standard. There is currently no objective measurement for concussion and the reliance on subjective reporting and clinical judgement is imperfect.

In previous clinical studies the investigators determined cutoff values of plasma phosphatidylcholines that provided strong indication that a concussion had occurred. Based on this data, the investigators have developed a custom assay, which will work together with a capillary blood collection device. The current clinical trial will be conducted in two parts. Part A will allow the investigators to determine precise AUC cut-off values for the propriety, novel custom assay, and in Part B the investigators will assess the safety and efficacy of this device for concussion diagnosis in adolescent athletes aged 13-17.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    13 to 17

Critères de participation

Inclusion Criteria:

1. Provision of signed and dated informed consent/assent form
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Male or female athletes, aged 13-17 inclusive

Exclusion Criteria:

1. Individuals who have suffered a known concussion within the 6 months prior to enrollment
2. Individuals who suffer from an acute neurological disorder
3. Known pregnancy

Lieu de l'étude

The Hill Academy
The Hill Academy
Caledon, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Jennifer Bell

Étude parrainée par
Neurolytixs
Participants recherchés
Plus d'informations
ID de l'étude: NCT05287997